Clinical trial
Aggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia
NCT00794963 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- May 31, 2010
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.